Advisory Board and Editors Cell Biology

MD, PhD, Associate Professor at the Faculty of Science, Department of Genetics and Evolution, University of Geneva, Switzerland. Elected Vice-Dean. Member of Academia-net. Post-doctoral stage at the ZMBH, Heidelberg, Germany; PhD in Life Sciences in Strasbourg, France; medical studies in Paris, France. Since my post-doc time, I study the molecular and cellular basis of regeneration, neurogenesis and aging and I use Hydra, a freshwater cnidarian polyp, as model system.

Professor of Radiation Oncology, Associate Chair for Research & Director of the Division of Radiation & Cancer Biology in the Department of Radiation Oncology. Head of the Radiation Biology Program in Stanford's Cancer Center, & Director of the Cancer Biology Interdisciplinary Graduate Program. Co-authored the 6th/7th editions of the textbook, "Radiation Biology for the Radiologist". Currently the Jack, Lulu and Sam Willson Professor in Cancer Biology at Stanford University School of Medicine

Dr. Gillespie is an evolutionary biologist with broad interests in organismal and molecular evolution. The major focus of his current research is deciphering the mechanisms by which obligate intracellular species of Rickettsiales (Alphaproteobacteria) invade, survive and replicate within eukaryotic cells.

In research funded by the National Institutes of Health, Dr. Gillespie utilizes phylogenetics, comparative genomics and bioinformatics to guide experimental research on various pathogenic species of Rickettsia and their associated arthropod vectors. His early research resulted in the reclassification of Rickettsia species and the identification of many lineage-specific pathogenicity factors. Through years of intense scrutinization of dozens of diverse rickettsial genomes, Dr. Gillespie and colleagues have described a large, dynamic mobilome for Rickettsia species, resulting in the identification of integrative conjugative elements as the vehicles for seeding Rickettsia genomes with many of the factors underlying obligate intracellular biology and pathogenesis. Via an iterative process of genome sequencing, phylogenomics, bioinformatics, and classical molecular biology and microbiology, Dr. Gillespie continues to lead and assist research projects on the characterization of rickettsial gene and protein function.

Co-founder and CSO of Celentyx Ltd.
Professor Emeritus of Cellular Immunology and Head of College of Medical and Dental Sciences Graduate School, University of Birmingham.
Raine Visiting Professor, University of Western Australia.

John Gordon is an internationally recognised authority on immune cell biology and immune cell-mediated diseases. For the past decade or so, John has been pioneering the field of Neuro-Immuno-Pharmacology. He is one of the world’s most highly cited researchers (www.ISIHighlyCited.com) and has a proven track record in the successful application of research within the field of translational medicine.

Gwyn is Professor of Cell Biology at the University of Glasgow where he has held a group leader position since 1989. He did his undergraduate and postgraduate work at the University of Southampton, studying lipid/protein interactions under the supervision of Tony Lee for his PhD. This was followed by postdoctoral work at Dartmouth Medical School where his interest in membrane trafficking began. His research focusses upon the control of glucose transport by insulin in adipocytes, muscle and cardiac tissue.

Emeritus Prof. of the Department of Zoology, University of Cambridge. Made a Fellow of the Royal Society in 1971, and knighted in 1995. He served as Master of Magdalene College, Cambridge, from 1995 to 2002. Awards include the 2012 Nobel Prize, the 1989 Wolf Prize in Medicine, the 2009 Albert Lasker Basic Medical Research award, the 1968 Scientific Medal of the Zoological Society, the 1987 Emperor Hirohito International Prize for Biology, & the 2001 Conklin Medal.

Max studied biochemistry and molecular biology in Argentina. In 2005, he was awarded a PhD in cell biology where he focused on the interactions between intracellular pathogens and the autophagic pathway. After that, he was in Gareth Griffiths Laboratory at EMBL, Heidelberg, Germany as a postdoctoral fellow of the von Humboldt foundation and EMBO focusing on the cell biology of macrophages and mycobacteria. In 2009, he became the head of the Junior Research Group “Phagosome Biology” at the Helmholtz Centre for Infection Research in Braunschweig, Germany. In 2012, he was recruited as a Programme Leader Track at the National Institute for Medical Research in London. Since 2015, he is a group leader at the Francis Crick Institute in London where he is developing imaging technologies and cellular models of infection to investigate the host-pathogen interactions in tuberculosis.